96.36
price down icon0.38%   -0.37
after-market Handel nachbörslich: 96.36
loading
Schlusskurs vom Vortag:
$96.73
Offen:
$96.74
24-Stunden-Volumen:
1.12M
Relative Volume:
1.19
Marktkapitalisierung:
$5.51B
Einnahmen:
$360.35M
Nettoeinkommen (Verlust:
$-149.57M
KGV:
-32.55
EPS:
-2.96
Netto-Cashflow:
$-81.27M
1W Leistung:
-1.93%
1M Leistung:
-3.78%
6M Leistung:
-39.82%
1J Leistung:
-21.51%
1-Tages-Spanne:
Value
$95.34
$97.42
1-Wochen-Bereich:
Value
$95.34
$100.33
52-Wochen-Spanne:
Value
$77.10
$163.71

Glaukos Corporation Stock (GKOS) Company Profile

Name
Firmenname
Glaukos Corporation
Name
Telefon
949-367-9600
Name
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Name
Mitarbeiter
995
Name
Twitter
@GlaukosCorp
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
GKOS's Discussions on Twitter

Vergleichen Sie GKOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
GKOS
Glaukos Corporation
96.36 5.61B 360.35M -149.57M -81.27M -2.96
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Glaukos Corporation Stock (GKOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-01 Herabstufung Wells Fargo Overweight → Equal Weight
2025-02-19 Hochstufung Mizuho Neutral → Outperform
2024-12-11 Hochstufung Citigroup Neutral → Buy
2024-12-06 Eingeleitet UBS Buy
2024-12-02 Herabstufung Morgan Stanley Equal-Weight → Underweight
2024-07-10 Herabstufung Citigroup Buy → Neutral
2024-05-06 Hochstufung Jefferies Hold → Buy
2023-12-21 Hochstufung JP Morgan Neutral → Overweight
2023-12-04 Eingeleitet Morgan Stanley Equal-Weight
2023-11-28 Eingeleitet Truist Buy
2023-11-08 Hochstufung Wells Fargo Equal Weight → Overweight
2023-06-07 Hochstufung Piper Sandler Neutral → Overweight
2022-12-22 Eingeleitet Mizuho Neutral
2022-12-19 Hochstufung JP Morgan Underweight → Neutral
2022-12-12 Hochstufung Citigroup Neutral → Buy
2022-10-14 Fortgesetzt Stephens Overweight
2022-10-04 Eingeleitet Needham Buy
2022-07-12 Hochstufung Stifel Hold → Buy
2022-02-03 Hochstufung William Blair Mkt Perform → Outperform
2022-01-19 Hochstufung Wells Fargo Underweight → Equal Weight
2022-01-18 Hochstufung BTIG Research Neutral → Buy
2021-11-03 Hochstufung Stephens Equal-Weight → Overweight
2021-07-26 Herabstufung Stephens Overweight → Equal-Weight
2021-07-20 Herabstufung Wells Fargo Equal Weight → Underweight
2021-07-14 Herabstufung Oppenheimer Outperform → Perform
2021-07-14 Herabstufung William Blair Outperform → Mkt Perform
2021-04-08 Hochstufung Oppenheimer Perform → Outperform
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2020-12-16 Hochstufung Citigroup Sell → Neutral
2020-12-09 Eingeleitet Oppenheimer Perform
2020-11-17 Hochstufung Wells Fargo Underweight → Equal Weight
2020-10-08 Herabstufung JP Morgan Neutral → Underweight
2020-06-15 Eingeleitet Jefferies Hold
2020-03-05 Eingeleitet Citigroup Sell
2020-02-28 Herabstufung JP Morgan Overweight → Neutral
2020-01-06 Hochstufung Berenberg Hold → Buy
2019-12-12 Herabstufung Wells Fargo Outperform → Underperform
2019-09-30 Herabstufung BofA/Merrill Buy → Underperform
2019-03-08 Eingeleitet BTIG Research Neutral
2018-08-30 Eingeleitet Berenberg Hold
2018-08-29 Hochstufung JP Morgan Neutral → Overweight
2018-08-03 Bestätigt Stifel Hold
2018-06-21 Herabstufung JP Morgan Overweight → Neutral
2018-04-13 Herabstufung Stifel Buy → Hold
2018-03-01 Bestätigt Cantor Fitzgerald Buy
2017-03-02 Bestätigt Cantor Fitzgerald Overweight
2017-01-06 Hochstufung Stifel Hold → Buy
2016-10-27 Eingeleitet Wells Fargo Outperform
Alle ansehen

Glaukos Corporation Aktie (GKOS) Neueste Nachrichten

pulisher
Jul 22, 2025

Why We're Not Concerned About Glaukos Corporation's (NYSE:GKOS) Share Price - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Glaukos Corporation Stock Analysis and ForecastExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Glaukos Corporation stockRapid wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Glaukos Corporation stock priceFree Daily Trading Room Entry - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

Is Glaukos Corporation a good long term investmentFree Stock Market Trend Analysis - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about Glaukos Corporation stock outlookFree Insider Trading Tips - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal

Jul 18, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Glaukos (GKOS) - Nasdaq

Jul 17, 2025
pulisher
Jul 16, 2025

BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $117 - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

(GKOS) Investment Report - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 14, 2025

Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS) - simplywall.st

Jul 14, 2025
pulisher
Jul 14, 2025

BTIG Increases Glaukos (GKOS) Price Target Ahead of Q2 Results | - GuruFocus

Jul 14, 2025
pulisher
Jul 10, 2025

Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - BioSpace

Jul 10, 2025
pulisher
Jul 09, 2025

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

Glaukos to Release Second Quarter 2025 Financial Results after M - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Press Release: Glaukos to Release Second Quarter 2025 Financial Results After Market Close on July 30 - 富途牛牛

Jul 09, 2025
pulisher
Jun 30, 2025

Glaukos Prepares for New Product Launches - Orange County Business Journal

Jun 30, 2025
pulisher
Jun 30, 2025

Glaukos Corporation(NYSE: GKOS) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

Glaukos gains EU certification for iStent infinite and other MIGS devices - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - BioSpace

Jun 26, 2025
pulisher
Jun 25, 2025

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies | GKOS Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Trend Tracker for (GKOS) - news.stocktradersdaily.com

Jun 25, 2025
pulisher
Jun 25, 2025

Glaukos Receives EU Regulatory Certification for Devices and Technologies to Treat Glaucoma - 富途牛牛

Jun 25, 2025
pulisher
Jun 24, 2025

Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS) - Seeking Alpha

Jun 24, 2025
pulisher
Jun 16, 2025

Glaukos Trades Higher Than Medical Peers NYSE Composite - Kalkine Media

Jun 16, 2025
pulisher
Jun 16, 2025

What Makes Glaukos (GKOS) a New Buy Stock - Yahoo Finance

Jun 16, 2025
pulisher
Jun 14, 2025

Trading (GKOS) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Canada

Jun 13, 2025
pulisher
Jun 11, 2025

Glaukos Corp (GKOS) Shares Up 6.05% on Jun 11 - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect? - sharewise

Jun 11, 2025
pulisher
Jun 10, 2025

Here’s Why Glaukos (GKOS) Shares Traded Lower in Q1 - Insider Monkey

Jun 10, 2025
pulisher
Jun 04, 2025

Stifel maintains buy rating on Glaukos stock, $115 target unchanged By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at Jefferies Conference: Eyeing Interventional Success By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at Jefferies Conference: Eyeing Interventional Success - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Stifel maintains buy rating on Glaukos stock, $115 target unchanged - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at William Blair Conference: Eyeing Innovative Growth By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

glaukos corp reports annual meeting voting results By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

glaukos corp reports annual meeting voting results - Investing.com

Jun 03, 2025

Finanzdaten der Glaukos Corporation-Aktie (GKOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):